Although there are many ways a patient can reduce the risk for diabetes or complications from diabetes, pharmacists have intimate knowledge of a patient
September 2017 Diabetes Supplement
Patient education and understanding the relationship between hyperglycemia, peripheral vascular disease, neuropathy, and foot complications are essential to reduce the potential for foot injury, ulceration, or amputation.
One of the biggest struggles facing patients today is ensuring they have the proper medications on hand and that they are taking their medications correctly.
Sodium-glucose co-transporter-2 inhibitors are a class of antihyperglycemic agents that can be used to improve glycemic control in the treatment of type 2 diabetes.
Many patients with T2D will require insulin therapy; however, these patients are also likely to develop insulin resistance over time.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
2
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
3
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
4
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
5
